APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume 19, Issue 3, Pages 351-357
Publisher
Springer Nature
Online
2013-02-19
DOI
10.1038/mp.2013.19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apolipoprotein E4 effects in Alzheimer’s disease are mediated by synaptotoxic oligomeric amyloid-β
- (2012) Robert M. Koffie et al. BRAIN
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
- (2012) Theresa R. Bomfim et al. JOURNAL OF CLINICAL INVESTIGATION
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- Identification of common variants associated with human hippocampal and intracranial volumes
- (2012) Jason L Stein et al. NATURE GENETICS
- Fast and accurate genotype imputation in genome-wide association studies through pre-phasing
- (2012) Bryan Howie et al. NATURE GENETICS
- From Alois to Amyvid: Seeing Alzheimer disease
- (2012) A. J. Furst et al. NEUROLOGY
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors
- (2011) Beben Benyamin et al. HUMAN MOLECULAR GENETICS
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Butyrylcholinesterase Is Associated With β-Amyloid Plaques in the Transgenic APPSWE/PSEN1dE9 Mouse Model of Alzheimer Disease
- (2011) Sultan Darvesh et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Mild Cognitive Impairment
- (2011) Ronald C. Petersen NEW ENGLAND JOURNAL OF MEDICINE
- Alzheimer's Disease: The Challenge of the Second Century
- (2011) D. M. Holtzman et al. Science Translational Medicine
- Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
- (2011) J. M. Castellano et al. Science Translational Medicine
- The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
- (2010) Michael W. Weiner et al. Alzheimers & Dementia
- Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans
- (2010) Andrew J. Saykin et al. Alzheimers & Dementia
- The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
- (2010) William J. Jagust et al. Alzheimers & Dementia
- Endophenotype: a conceptual analysis
- (2010) K S Kendler et al. MOLECULAR PSYCHIATRY
- The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects
- (2010) Kristel Sleegers et al. TRENDS IN GENETICS
- Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE ε4, and hyperhomocysteinemia in neurodegenerative dementias
- (2009) Roger M. Lane et al. MEDICAL HYPOTHESES
- The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase
- (2009) Taher Darreh-Shori et al. NEUROBIOLOGY OF AGING
- The Role of Apolipoprotein E in Alzheimer's Disease
- (2009) Jungsu Kim et al. NEURON
- Synergistic effect of apolipoprotein E ϵ4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimerʼs disease
- (2009) Roger Lane et al. Pharmacogenetics and Genomics
- Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: Methodological considerations
- (2009) Steven G. Potkin et al. Cognitive Neuropsychiatry
- SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap
- (2008) A. D. Johnson et al. BIOINFORMATICS
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
- Treatment Options in Alzheimer’s Disease: Maximizing Benefit, Managing Expectations
- (2008) Martin R. Farlow et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Estimation of the multiple testing burden for genomewide association studies of nearly all common variants
- (2008) Itsik Pe'er et al. GENETIC EPIDEMIOLOGY
- Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients
- (2008) Andrea Tasker et al. NEUROSCIENCE LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now